metformin has been researched along with ku 55933 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, RG; Cutz, JC; Harding, S; Liu, C; Rashid, A; Sanli, T; Singh, G; Tsakiridis, T; Wright, J | 1 |
| Avizonis, D; Bazile, M; Hashemi, S; Javeshghani, S; Pollak, MN; St Pierre, J; Zakikhani, M | 1 |
2 other study(ies) available for metformin and ku 55933
| Article | Year |
|---|---|
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Topics: AMP-Activated Protein Kinases; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Enzyme Activation; Female; G2 Phase; Humans; Lung Neoplasms; Male; Metformin; Morpholines; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Pyrones; Radiation Tolerance; RNA, Small Interfering; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |
Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Citric Acid; Citric Acid Cycle; DNA-Binding Proteins; Fumarates; HeLa Cells; Hep G2 Cells; Humans; Hypoglycemic Agents; Ketoglutaric Acids; Malates; Membrane Potential, Mitochondrial; Metformin; Morpholines; Oxygen Consumption; Phosphorylation; Protein Serine-Threonine Kinases; Pyrones; Succinic Acid; Tumor Suppressor Proteins | 2012 |